News
Parkinson's charity partners Biognosys on biomarker project
A new R&D project will try to develop assays for LRRK2, a biomarker linked to Parkinson's that has emerged as a major drug target in the disease.
News
Amazon launches its AI drug discovery platform
Amazon has pitched an AI-powered drug discovery platform to the biopharma industry that combines in silico and wet-lab work in a single application.
R&D
From genetic insight to Phase 3: What rare neurology require...
Rare neurology is not defined by a lack of scientific opportunity or capital.
News
FDA renews criticism of trial sponsors over transparency
The FDA has launched a drive to get clinical trial sponsors to disclose the results of studies – even if they are negative.
News
Novo Nordisk partners OpenAI on R&D "transformation"
Seeking an R&D edge, Novo Nordisk has become the latest big pharma group to forge an alliance with tech giant OpenAI.
Debates & Insights
News
Press Releases
Editor's Picks
Editor's Picks
